Conference abstractPublished 24 Jul 2017
Variation in response to opioid analgesics: A study on single nucleotide polymorphisms in human COMT and cytochrome P450 D6 genes
St Luke’s Medical Center, Philippines
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Opioids are potent analgesics and remain to be the mainstay in the management of cancer- related pain. The variation in response to opioid analgesics is partly due to genetic variability. A hospital-based cross-sectional study was conducted to investigate the association between catechol-0-methyltrasferase (COMT) and cytochrome P450 D6 (CYP2D6*10) genetic polymorphisms and opioid consumption among cancer patients. Polymorphisms in the COMT rs4680 and CYP2D6*10 rs106585 genes were identified through restriction fragment length polymorphism and nucleotide sequencing. Cancer patients with moderate pain (NRS 4-6) were prescribed with tramadol, while those having severe pain (NRS 7-9) were given morphine. None of the single nucleotide polymorphisms in the two candidate genes COMT and CYP2D6*10 showed significant associations with opioid consumption among cancer pain patients. It is likely that multiple genes rather than single gene may affect drug pharmacokinetics and pharmacodynamics and together with environmental factors may influence the clinical efficacy of opioid analgesics.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectAnaesthesia & Pain
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Michael O Baclig”